Puma Biotechnology Inc
PBYI
Get informed when a big investor buys or sells
+ FollowMarket Cap$523.76M
Close$
$15.97
51.8% upside
Current Fair Value
51.8% upsideUndervalued by 51.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $523.76 Million |
|---|---|
| Enterprise Value | $492.07 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.62 |
| Beta | 1.21 |
| Outstanding Shares | 50,939,946 |
Return
| Return on Equity | 19.22% |
|---|---|
| Return on Assets | 13.82% |
| Return on Invested Capital | 22.67% |
Valuation & Multiples
| P/E Ratio | 19.19 |
|---|---|
| PEG | 48.14 |
| Price to Sales | 2.63 |
| Price to Book Ratio | 5.26 |
| Enterprise Value to Revenue | 2.13 |
| Enterprise Value to EBIT | 15.19 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$0.04
Average shareholder expectationRevenue Estimate
$53.00 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.09
Average shareholder expectationRevenue Estimate
$57.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 29.50% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 76.18% |
|---|---|
| Total Invested | $29,551▼ 99.99% |
| Investors Holding | 4▼ 162.00% |
ESG Score
No data